Literature DB >> 19995476

Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence.

M Harley1, I Kelleher, M Clarke, F Lynch, L Arseneault, D Connor, C Fitzpatrick, M Cannon.   

Abstract

BACKGROUND: Adolescent cannabis use has been shown in many studies to increase the risk of later psychosis. Childhood trauma is associated with both substance misuse and risk for psychosis. In this study our aim was to investigate whether there is a significant interaction between cannabis use and childhood trauma in increasing the risk for experiencing psychotic symptoms during adolescence.
METHOD: Psychiatric interviews using the Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS) semi-structured instrument were carried out with 211 adolescents aged between 12 and 15 years and their parents as part of a population-based study. The interview enquired about early traumatic events, cannabis use and psychiatric symptoms in adolescence.
RESULTS: In separate analyses both cannabis use and childhood trauma were significantly associated with risk of experiencing psychotic symptoms. However, the presence of both childhood trauma and early cannabis use significantly increased the risk for psychotic symptoms beyond the risk posed by either risk factor alone, indicating that there was a greater than additive interaction between childhood trauma and cannabis use.
CONCLUSION: Our finding of a greater than additive interaction between childhood trauma and cannabis use may have implications for the identification of individuals at high risk of experiencing psychotic symptoms. For example, measures to actively discourage or intensively treat cannabis use in children and adolescents who have experienced abuse may help to prevent the development of psychosis in this vulnerable group. Our findings require replication in larger samples to confirm this interaction effect.

Entities:  

Mesh:

Year:  2009        PMID: 19995476     DOI: 10.1017/S0033291709991966

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  40 in total

Review 1.  Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.

Authors:  Marc W Manseau; Donald C Goff
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 2.  Trauma and the psychosis spectrum: A review of symptom specificity and explanatory mechanisms.

Authors:  Lauren E Gibson; Lauren B Alloy; Lauren M Ellman
Journal:  Clin Psychol Rev       Date:  2016-08-31

3.  The impact of adolescent cannabis use, mood disorder and lack of education on attempted suicide in young adulthood.

Authors:  Mary Catherine Clarke; Helen Coughlan; Michelle Harley; Dearbhla Connor; Emmet Power; Fionnuala Lynch; Carole Fitzpatrick; Mary Cannon
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

4.  [Trauma and psychosis--part 2. On the association of early childhood maltreatment and risk of psychosis in general population].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2012-10-05

Review 5.  Sensorimotor gating deficits in "two-hit" models of schizophrenia risk factors.

Authors:  Asma Khan; Susan B Powell
Journal:  Schizophr Res       Date:  2017-10-22       Impact factor: 4.939

6.  Clinical correlates of maltreatment and traumatic experiences in childhood and adolescence among predominantly African American, socially disadvantaged, hospitalized, first-episode psychosis patients.

Authors:  Claire E Ramsay; Peggy Flanagan; Stephanie Gantt; Beth Broussard; Michael T Compton
Journal:  Psychiatry Res       Date:  2011-06-12       Impact factor: 3.222

7.  Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.

Authors:  Luca Pauselli; Michael L Birnbaum; Beatriz Paulina Vázquez Jaime; Enrico Paolini; Mary E Kelley; Beth Broussard; Michael T Compton
Journal:  Schizophr Res       Date:  2018-02-04       Impact factor: 4.939

8.  Impact of Cannabis Use on the Development of Psychotic Disorders.

Authors:  Samuel T Wilkinson; Rajiv Radhakrishnan; Deepak Cyril D'Souza
Journal:  Curr Addict Rep       Date:  2014-06-01

9.  Predictors of a clinical high risk status among individuals with a family history of psychosis.

Authors:  Jacqueline Stowkowy; Jean Addington
Journal:  Schizophr Res       Date:  2013-04-20       Impact factor: 4.939

10.  Telepsychotherapy with Youth at Clinical High Risk for Psychosis: Clinical Issues and Best Practices during the COVID-19 Pandemic.

Authors:  Joseph S DeLuca; Nicole D Andorko; Doha Chibani; Samantha Y Jay; Pamela J Rakhshan Rouhakhtar; Emily Petti; Mallory J Klaunig; Elizabeth C Thompson; Zachary B Millman; Kathleen M Connors; LeeAnn Akouri-Shan; John Fitzgerald; Samantha L Redman; Caroline Roemer; Miranda A Bridgwater; Jordan E DeVylder; Cheryl A King; Steven C Pitts; Shauna P Reinblatt; Heidi J Wehring; Kristin L Bussell; Natalee Solomon; Sarah M Edwards; Gloria M Reeves; Robert W Buchanan; Jason Schiffman
Journal:  J Psychother Integr       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.